593 related articles for article (PubMed ID: 20494700)
1. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
Tsochatzis EA; Germani G; Burroughs AK
Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
[TBL] [Abstract][Full Text] [Related]
2. Transarterial therapies for hepatocellular carcinoma.
Tsochatzis EA; Fatourou EM; Triantos CK; Burroughs AK
Recent Results Cancer Res; 2013; 190():195-206. PubMed ID: 22941022
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival.
Grieco A; Marcoccia S; Miele L; Marmiroli L; Caminiti G; Ragazzoni E; Cotroneo AR; Cefaro GA; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2003; 50(49):207-12. PubMed ID: 12630024
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial therapies for hepatocellular carcinoma: where do we stand?
Liapi E; Geschwind JF
Ann Surg Oncol; 2010 May; 17(5):1234-46. PubMed ID: 20405328
[TBL] [Abstract][Full Text] [Related]
5. Transarterial chemoembolization for hepatocellular carcinoma.
Lau WY; Yu SC; Lai EC; Leung TW
J Am Coll Surg; 2006 Jan; 202(1):155-68. PubMed ID: 16377509
[No Abstract] [Full Text] [Related]
6. Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial.
Okusaka T; Kasugai H; Shioyama Y; Tanaka K; Kudo M; Saisho H; Osaki Y; Sata M; Fujiyama S; Kumada T; Sato K; Yamamoto S; Hinotsu S; Sato T
J Hepatol; 2009 Dec; 51(6):1030-6. PubMed ID: 19864035
[TBL] [Abstract][Full Text] [Related]
7. [Acute renal failure as a complication of transarterial chemoembolization in a patient with hepatocellular carcinoma].
La Spada E; La Spada M; Brusca T; Campagna ME; Di Gesaro V; Terranova A; Sandonato L; Soresi M
Recenti Prog Med; 2007 Apr; 98(4):232-5. PubMed ID: 17547360
[TBL] [Abstract][Full Text] [Related]
8. Interventional radiology for hepatocellular carcinoma.
Loffroy R
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):299-309. PubMed ID: 21769079
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
[TBL] [Abstract][Full Text] [Related]
10. Subselective intra-arterial chemotherapy infusion in the treatment of hepatocellular carcinoma.
Daniels JR; Wallman M
Semin Oncol; 2010 Apr; 37(2):83-8. PubMed ID: 20494699
[TBL] [Abstract][Full Text] [Related]
11. Chemoembolization in patients at high risk: results and complications.
Kiely JM; Rilling WS; Touzios JG; Hieb RA; Franco J; Saeian K; Quebbeman EJ; Pitt HA
J Vasc Interv Radiol; 2006 Jan; 17(1):47-53. PubMed ID: 16415132
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel.
Cheng AL; Amarapurkar D; Chao Y; Chen PJ; Geschwind JF; Goh KL; Han KH; Kudo M; Lee HC; Lee RC; Lesmana LA; Lim HY; Paik SW; Poon RT; Tan CK; Tanwandee T; Teng G; Park JW
Liver Int; 2014 Feb; 34(2):174-83. PubMed ID: 24251922
[TBL] [Abstract][Full Text] [Related]
13. Current concepts in transarterial chemoembolization of hepatocellular carcinoma.
Huppert P
Abdom Imaging; 2011 Dec; 36(6):677-83. PubMed ID: 21674193
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
Kim JH; Yoon HK; Kim SY; Kim KM; Ko GY; Gwon DI; Sung KB
Aliment Pharmacol Ther; 2009 Jun; 29(12):1291-8. PubMed ID: 19392861
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation and chemoembolization for hepatocellular carcinoma.
Georgiades CS; Hong K; Geschwind JF
Cancer J; 2008; 14(2):117-22. PubMed ID: 18391617
[TBL] [Abstract][Full Text] [Related]
17. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
Fidelman N; Kerlan RK
AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
[TBL] [Abstract][Full Text] [Related]
18. Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey.
Huo T; Huang YH; Wu JC; Chiang JH; Lee PC; Chang FY; Lee SD
Aliment Pharmacol Ther; 2004 Jun; 19(12):1301-8. PubMed ID: 15191512
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions.
Maleux G; van Malenstein H; Vandecaveye V; Heye S; Vaninbroukx J; Nevens F; Verslype C
Dig Dis; 2009; 27(2):157-63. PubMed ID: 19546554
[TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]